Pharmacological Mechanisms Underlying the Association of Antipsychotics with Metabolic Disorders
Obesity and metabolic syndrome in association with an increased risk of cardiovascular disease and type II diabetes are significant problems that contribute to lower life expectancy of patients with schizophrenia. Understanding the pharmacological mechanisms of the current antipsychotic treatment is...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medical University Publishing House Craiova
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006340/ |